Table 4.
SNP | BMI-SDS1 | Genotype | n (%) | Mean ± SD | Estimate | 95% CI | p value2 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning of the intervention | |||||||||||||
rs17782313 | all subjects | CC | 43 (11.72) | 2.39 ± 0.46 | 0.044 | −0.030 to 0.119 | 0.244 | ||||||
CT | 149 (40.60) | 2.45 ± 0.50 | |||||||||||
TT | 175 (47.68) | 2.36 ± 0.50 | |||||||||||
females | CC | 20 (9.76) | 2.28 ± 0.49 | 0.009 | −0.098 to 0.117 | 0.866 | |||||||
CT | 87 (42.44) | 2.45 ± 0.52 | |||||||||||
TT | 98 (47.8) | 2.36 ± 0.51 | |||||||||||
males | CC | 23 (14.2) | 2.49 ± 0.43 | 0.079 | −0.016 to 0.174 | 0.107 | |||||||
CT | 62 (38.27) | 2.45 ± 0.48 | |||||||||||
TT | 77 (47.53) | 2.36 ± 0.50 | |||||||||||
rs12970134 | all subjects | AA | 52 (14.17) | 2.39 ± 0.48 | 0.057 | −0.015 to 0.129 | 0.124 | ||||||
AG | 149 (40.60) | 2.47 ± 0.51 | |||||||||||
GG | 166 (45.23) | 2.34 ± 0.49 | |||||||||||
females | AA | 27 (13.17) | 2.27 ± 0.48 | 0.020 | −0.081 to 0.122 | 0.695 | |||||||
AG | 85 (41.46) | 2.49 ± 0.53 | |||||||||||
GG | 93 (45.37) | 2.33 ± 0.50 | |||||||||||
males | AA | 52 (14.17) | 2.39 ± 0.48 | 0.103 | 0.010–0.197 | 0.032 | |||||||
AG | 149 (40.60) | 2.47 ± 0.51 | |||||||||||
GG | 166 (45.23) | 2.34 ± 0.49 | |||||||||||
After the intervention (BMI-SDS reduction) | |||||||||||||
rs17782313 | all subjects | CC | 43 (11.72) | 0.29 ± 0.37 | 0.035 | −0.014 to 0.084 | 0.163 | ||||||
CT | 149 (40.60) | 0.23 ± 0.35 | |||||||||||
TT | 175 (47.68) | 0.22 ± 0.30 | |||||||||||
females | CC | 20 (9.76) | 0.44 ± 0.38 | 0.086 | 0.013–0.159 | 0.021 | |||||||
CT | 87 (42.44) | 0.21 ± 0.36 | |||||||||||
TT | 98 (47.8) | 0.19 ± 0.19 | |||||||||||
males | CC | 23 (14.2) | 0.17 ± 0.31 | −0.016 | −0.079 to 0.046 | 0.547 | |||||||
CT | 62 (38,271) | 0.27 ± 0.33 | |||||||||||
TT | 77 (47.53) | 0.25 ± 0.24 | |||||||||||
rs12970134 | all subjects | AA | 52 (14.17) | 0.32 ± 0.38 | 0.039 | −0.008 to 0.087 | 0.102 | ||||||
AG | 149 (40.60) | 0.22 ± 0.34 | |||||||||||
GG | 166 (45.23) | 0.22 ± 0.30 | |||||||||||
females | AA | 27 (13.17) | 0.44 ± 0.39 | 0.092 | 0.024–0.160 | 0.009 | |||||||
AG | 85 (41.46) | 0.19 ± 0.35 | |||||||||||
GG | 93 (45.37) | 0.19 ± 0.34 | |||||||||||
males | AA | 25 (15.43) | 0.20 ± 0.33 | −0.019 | −0.081 to 0.043 | 0.614 | |||||||
AG | 64 (39.51) | 0.24 ± 0.33 | |||||||||||
GG | 73 (45.06) | 0.26 ± 0.23 |
Effect of one copy of the minor (risk) allele in the additive genetic model as determined by linear regression adjusted for age (or age and sex in the analysis of both sexes) in the beginning of the intervention.
Positive values indicate relative weight reduction in units of BMI-SDS after the intervention.
Effect for one copy of the minor (risk) allele in the additive genetic model as determined by linear regression adjusted for age and BMI-SDS at the beginning of the intervention program (or age, BMI-SDS at the beginning of the intervention program and sex in the analysis of both sexes)
Two-sided p value.